Literature DB >> 27516

Metabolism of prostacyclin in blood vessels.

P Y Wong, F F Sun, J C McGiff.   

Abstract

The activity of 15-hydroxyprostaglandin dehydrogenase has been shown to be high in both mesenteric arteries and veins; the present study suggests that it may be responsible for the inactivation of prostacyclin (PGI2). The cytoplasmic fractions of bovine mesenteric arteries and veins were incubated with radiolabeled PGI2 in the presence of NAD+ or NADP+. The substrate was rapidly converted to a product, which was isolated and identified as 6,15-diketo prostaglandin F1alpha, (6,15-diketo-PGF1alpha) by thin layer chromatography and gas chromatography-mass spectrometry. The initial reaction rate began to level off after less than 1 min of incubation at 37 degrees C. When radiolabeled 6-keto-PGF1alpha, the stable hydrolysis product of PGI2, was used as substrate under the same conditions, 97% was recovered unmetabolized after 2 min of incubation. Catabolism of PGI2 may be a major determinant of its levels in blood vessels and, therefore, may be of crucial importance to regulating the action of PGI2. Further, estimation of PGI2 generation by either tissues or organs may be misleading if only 6-keto-PGF1alpha is measured.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 27516

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374)--equipotent to PGI2 in vitro.

Authors:  K Schrör; H Darius; R Matzky; R Ohlendorf
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-06       Impact factor: 3.000

Review 2.  The prostanoids in hemostasis and thrombosis: a review.

Authors:  J B Smith
Journal:  Am J Pathol       Date:  1980-06       Impact factor: 4.307

3.  The role of prostaglandins in the endothelium-mediated vasodilatory response to hypoxia.

Authors:  R Busse; U Förstermann; H Matsuda; U Pohl
Journal:  Pflugers Arch       Date:  1984-05       Impact factor: 3.657

4.  In vitro activity of nicotinamide adenine dinucleotide- and nicotinamide adenine dinucleotide phosphate-linked 15-hydroxyprostaglandin dehydrogenases in placentas from normotensive and preeclamptic/eclamptic pregnancies.

Authors:  J Jarabak; J D Watkins; M Lindheimer
Journal:  J Clin Invest       Date:  1987-10       Impact factor: 14.808

5.  Prostaglandin E2 inhibits tumor necrosis factor-alpha RNA through PKA type I.

Authors:  Jennifer B Stafford; Lawrence J Marnett
Journal:  Biochem Biophys Res Commun       Date:  2007-12-03       Impact factor: 3.575

6.  Tromboxane B2 inhibits the pulmonary inactivation of prostaglandin E2 in the dog.

Authors:  T M Fitzpatrick; L S Friedman; P A Kot; P W Ramwell
Journal:  Br J Pharmacol       Date:  1980-10       Impact factor: 8.739

7.  Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man.

Authors:  S L Swartz; G H Williams; N K Hollenberg; L Levine; R G Dluhy; T J Moore
Journal:  J Clin Invest       Date:  1980-06       Impact factor: 14.808

8.  Synthesis of prostacyclin from platelet-derived endoperoxides by cultured human endothelial cells.

Authors:  A J Marcus; B B Weksler; E A Jaffe; M J Broekman
Journal:  J Clin Invest       Date:  1980-11       Impact factor: 14.808

Review 9.  Pulmonary biosynthesis and metabolism of prostaglandins and related substances.

Authors:  T E Eling; A I Ally
Journal:  Environ Health Perspect       Date:  1984-04       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.